“…There is growing evidence that adjuvant platinum-based chemotherapy, which has been shown to be of benefit in cases of adenocarcinoma of the fallopian tube 18,19 used alone or in combination with adjuvant radiotherapy may also improve survival in cases of tubal MMMT. 5,[7][8][9][10]12,17,20 Gemcitabine has been shown to be useful in treating recurrent ovarian cancer as well as platinum-refractory ovarian and fallopian tube cancers. [21][22][23] Histologically, MMMT are biphasic tumours which are composed of an intimate mixture of carcinomatous components (usually well-differentiated or poorly differentiated adenocarcinoma) and sarcomatous elements.…”